Management of diverticular disease: Is there room for rifaximin?

Chemotherapy

Volumn 51, Issue SUPPL. 1, 2005, Pages 110-114

  Papi, Claudio ^a   Koch, Maurizio ^a   Capurso, Lucio ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

Antibiotics; Diverticular disease; Diverticulitis; Rifaximin

Indexed keywords

ANTIBIOTIC AGENT; BULKING AGENT; MANNAN; NEOMYCIN; RIFAXIMIN;

ANTIBIOTIC THERAPY; BACTERIAL OVERGROWTH; BRAN; COLON DIVERTICULOSIS; COLON MOTILITY; DIARRHEA; DIETARY FIBER; FLATULENCE; HUMAN; INFECTION PREVENTION; INTESTINE PRESSURE; PRIORITY JOURNAL; REVIEW; SIGMOID; SYMPTOM; TRAVELLER DIARRHEA;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS; DIVERTICULITIS; DIVERTICULUM, COLON; HUMANS; MANNANS; RIFAMYCINS;

EID: 18644386205     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081997     Document Type: Review

References (49)

1. Parks TG: Natural history of diverticular disease of the colon. Clin Gastroenterol 1975;4:53-69.
2. Naitove A, Almy TP: Diverticular disease of the colon; in Sleisenger MH, Fordtran JS (eds): Gastrointestinal Disease: Pathophysiology, Diagnosis. Management, ed 4. Philadelphia, WB Saunders, 1989, pp 1419-1434.
3. Almy TP, Howell DA: Diverticular disease of the colon. N Engl J Med 1980;302:324-331.
4. Roberts PL, Veidenheimer MC: Diverticular disease of the colon; in Bayless TM (ed): Current Therapy in Gastroenterology and Liver Disease. Toronto, BC Decker, 1990, vol 3, pp 416-419.
5. Painter NS, Burkitt DP: Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol 1975;4:3-21.
6. Narasaka T, Watanabe H, Yamagata S, Munakata A, Tajima T, Matatsunaga F: Statistical analysis of diverticulosis of the colon. Tohoku J Exp Med 1975;115:271-275.
7. Kyle J, Adesola AD, Tinckler LF, De Beaux J: Incidence of diverticulitis. Scand J Gastroenterol 1967;2:44-47.
8. Painter NS: The high fiber diet in the treatment of diverticular disease of the colon. Postgrad Med J 1974;50:629-635.
9. Burkitt DP: Dietary fiber and 'pressure diseases'. J R Coll Physicians Lond 1975;9:138-147.
10. Manousos O, Day NE, Tzonou A, Papadimitriou C, Kapetanakis A, Polychronopoulou-Trichopoulou A, Trichopoulou D: Diet and other factors in the aetiology of diverticulosis: An epidemiological study in Greece. Gut 1985;26:544-549.
11. Brodribb AJM, Humphreys DM: Diverticular disease: Three studies. I. Relation to other disorders and fibre intake. Br Med J 1976;i:424-430.
12. Gear JSS, Ware A, Fursdon P, Mann JI, Nolan DJ, Brodribb AJ, Vessey MP: Symptomless diverticular disease and intake of dietary fibre. Lancet 1979;i:511-514.
13. Aldoori WH, Giovannucci EL, Rockett HRH, Sampson L, Rimm EB, Willet WC: A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr 1998;128:717-719.
14. Chia JG, Wilde CC, Ngoi SS, Goh PM, Ong CL: Trends of diverticular disease of the large bowel in a newly developed country. Dis Colon Rectum 1991;34:498-501.
15. Torsoli A, Inoue M, Manousos O, Smith A, Van Steensel CJ: Diverticular disease of the colon: Data relevant to treatment. Gastroenterol Int 1991;4:3-20.
16. Farrell RJ, Farrell JJ, Morrin MM: Diverticular disease in the elderly. Gastroenterol Clin North Am 2001;30:475-496.
17. Brodribb AJM: Treatment of symptomatic diverticular disease with a high-fibre diet. Lancet 1977;i:664-666.
18. Ornstein MH, Littlewood ER, Baird IM, Fowler J, Cox AG: Are fibre supplements really necessary in diverticular disease of the colon? A controlled trial. Br Med J (Clin Res Ed) 1981;282:1629-1630.
19. Weinreich J: The treatment of diverticular disease. Scand J Gastroenterol Suppl 1982;79:128-129.
20. Ewerth S, Ahlberg J, Holmstrom B, Persson U, Uden R: Influence on symptoms and transit time of Vi-SiblinR in diverticular disease. Acta Chir Scand Suppl 1980;500:40-59.
21. Solotof JI, Gudmand Hoyer E, Kreg B, Kristensen E, Wolff HR: A double blind trial of wheat bran on symptoms of irritable bowel syndrome. Lancet 1976;i:270-272.
22. Hodgson WJB: The placebo effect: Is it important in diverticular disease? Am J Gastroenterol 1977;67:157-162.
23. Longstreth GF, Fox DD, Youkeles L, Forsythe AB, Wolochow DA: Psyllium therapy in the irritable bowel syndrome. Ann Intern Med 1981;95:53-56.
24. Stollman NH, Raskin JB: Diagnosis and management of diverticular disease of the colon in adults. Am J Gastroenterol 1999;94:3110-3121.
25. Ritchie L: Similarity of bowel distension characteristics in the irritable bowel syndrome and diverticulosis. Gut 1977;18:990.
26. Levitt MD, Bond JH: Volume, composition and source of intestinal gas. Gastroenterology 1970;59:921-929.
27. Strocchi A, Levitt MD: Intestinal gas: in Sleisenger MH, Fordtran JS (eds): Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, ed 5. Philadelphia, Saunders, 1993, pp 1035-1042.
28. Bjorneklett A, Midvedt T: Influence of three antimicrobial agents - penicillin, metronidazole and doxycyclin - on the intestinal microflora of healthy humans. Scand J Gastroenterol 1988;94:928-932.
29. Rao SC, Edwards CA, Austen CJ, Bruce C, Read NW: Impaired colonic fermentation of carbohydrate after ampicillin. Gastroenterology 1988;94:928-932.
30. Di Stefano M, Strocchi A, Malservisi S, Veneto G, Ferrieri A, Corazza GR: Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms. Aliment Pharmacol Ther 2000;14:1001-1008.
31. Stephen AM, Cummings JH: Mechanism of action of dietary fiber in the human colon. Nature 1980;284:283-284.
32. MacFarlane GT, Cummings JH: The colonic flora, fermentation and large bowel digestive function; in Phillips SF, Pemberton JH, Shorter RG (eds): The Large Intestine: Physiology, Pathophysiology and Disease. New York, Raven. 1991, pp 51-92.
33. Stephen AM, Cummings JH: Water holding by dietary fibre in vitro and its relationship to fecal output in man. Gut 1979;20:722-729.
34. Kurpad AV, Shetty PS: Effects of antimicrobial therapy on fecal bulking. Gut 1986;27:55-58.
35. Gillis JC, Brogden RN: Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gatrointestinal bacteria. Drugs 1995;49:467-484.
36. Vinci M, Gatto A, Giglio A, Raciti T, D'Avola G, Di Stefano B, Salanitri G, Di Stefano F: Double blind clinical trial on infectious diarrhoea therapy: Rifaximin versus placebo. Curr Ther Res 1984;36:92-99.
37. Alvisi V, D'Ambrosi A, Loponte A, Pazzi P, Greco A, Zangirolami A, Palazzini E: Rifaximin, a rifamycin derivative for use in the treatment of intestinal bacterial infections in seriously disabled patients. J Int Med Res 1987;15: 49-56.
38. DuPont HL, Jiang ZD, Ericsson CD, Adachi JA, Mathewson JJ, DuPont MW, Palazzini E, Riopel LM, Ashley D, Martinez-Sandoval F: Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: A randomized, double-blind clinical trial. Clin Infect Dis 2001;1:1807-1815.
39. Cottone M, Pagliaro L: Rifaximin versus neomycin in the treatment of portosystemic encephalopathy. Ital J Gastroenterol 1991;23:403-407.
40. Pedretti G, Calzetti C, Missale G, Ficcadori F: Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double blind randomized trial. Ital J Gastroenterol 1991;23:175-178.
41. Di Stefano M, Malservisi S, Veneto G, Ferrieri A, Corazza GR: Rifaximin versus chlortetracycline in the short term treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther 2000;14:551-556.
42. Gruttaduria G, La Barbera F, Gutaia G, Salanitri G: Prevention of infection of colonic surgery by rifaximin. A controlled, prospective randomized trial. Eur Rev Med Pharmacol Sci 1987;9:101-105.
43. Papi C, Ciaco A, Koch M, Capurso L, Camarri E, Ferrieri A, Guardascione F, Miglio F, Minoli G, Terruzzi V, Parodi MC, Riegler G, Russo A: Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Ital J Gastroenterol 1992;24:452-456.
44. Latella G, Pimpo MT, Sottili S, Zippi M, Viscido A, Chiaramonte M, Frieri G: Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 2003;18:55-62.
45. Papi C, Ciaco A, Koch M, Capurso L, Diverticular Disease Study Group: Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 1995;9:33-39.
46. Porta E, Germano A, Ferrieri A, Koch M: The natural history of diverticular disease of the colon: A role for antibiotics in preventing complications? A retrospective study. Eur Rev Med Pharmacol Sci 1994;16:33-39.
47. Thompson WG, Patel DG, Tao N, Nair RC: Does uncomplicated diverticular disease produce symptoms? Dig Dis Sci 1982;27:605-608.
48. Thompson WG, Patel DG: Clinical picture of diverticular disease of the colon. Clin Gastroenterol 1986;4:903-916.
49. Gold MH, Carlson GM, Mathias JR: Colonic myoelectric activity in diverticulosis. Gastroenterology 1979;76:1139.